Evidence map›Paper›PMID 34457228›Full record

ArticleTherapeutic advances in chronic disease2021

Melatonin restores osteoporosis-impaired osteogenic potential of bone marrow mesenchymal stem cells and alleviates bone loss through the

Jun Zhang, Guoliang Jia, Pan Xue, Zhengwei Li

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in chronic disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Nutraceuticals in osteoporosis prevention.Frontiers in nutrition · 2024
    Review
  6. Article
  7. Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2023
    Review
  8. IRF-1-inhibited lncRNA XIST regulated the osteogenic differentiation via miR-450b/FBXW7 axis.Apoptosis : an international journal on programmed cell death · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Melatonin and the Programming of Stem Cells.International journal of molecular sciences · 2022
    Review
  16. The Role of SIRT3 in the Osteoporosis.Frontiers in endocrinology · 2022
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jun ZhangDepartment of Orthopedics, The Second Hospital of Jilin University, Changchun, P.R. China.
Guoliang JiaDepartment of Orthopedics, The Second Hospital of Jilin University, Changchun, P.R. China.
Pan XueDepartment of Orthopedics, The Second Hospital of Jilin University, Changchun, P.R. China.
Zhengwei LiDepartment of Orthopedics, The Second Hospital of Jilin University, No. 218, Ziqiang Road, Changchun, Jilin Province 130041, P.R. China.ORCID https://orcid.org/0000-0002-3795-1016
Second Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies reported that melatonin exerts its effect on mesenchymal stem cell (MSC) survival and differentiation into osteogenic and adipogenic lineage. In the current study we aimed to explore the effect of melatonin on osteoporosis and relevant mechanisms.

methodsReal-time qualitative polymerase chain reaction (RT-qPCR) and Western blot analysis were conducted to determine expression of

resultsMelatonin prevented bone loss in OVX mice. Melatonin increased ALP expression and reduced TRAP5b expression.

conclusionMelatonin could potentially enhance osteogenic differentiation of BMSCs and retard bone loss through the

Indexed as

bone marrow mesenchymal stem cellsHGFmelatoninosteoporosisPTENWnt/β-catenin

Identifiers

PMID34457228
PMCPMC8392808
OpenAlexW3194196691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.